A metanalysis by Bray et al
It produced 20.4% weight loss in the Phase 3 REDEFINE 1 trial and is not yet FDA-approved
Reduced food and fluid intake on GLP-1 medications can cause electrolyte imbalances, manifesting as muscle cramps, headaches, or irregular heartbeat
Schedule a consultation with our specialists today and take the first step towards the beauty and figure of your dreams!
Exact requirements, including income limits or medical criteria, are still being finalized, so patients should consult their doctor and check the official TrumpRX resources for updates
The Loss of Exclusivity (LOE) of semaglutide in China, Brazil, Canada and India in 2026 will result in the availability of cheaper generics in these countries (and possibly neighbouring countries via parallel import)